The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain.

The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain. While symptoms can now be better managed with lifelong treatment, there is ...

Single ascending dose data show IMC-I109V has manageable safety profile and antiviral activityIMC-I109V is a bispecific T cell receptor targeting ...

Immunocore reports third quarter financial results and provides a business update KIMMTRAK® (tebentafusp-tebn) net revenues of $103.7 million in ...

Scientists from Oxford's Radcliffe Department of Medicine have achieved the most detailed view yet of how DNA folds and ...

A research team at Ruhr University Bochum, Germany, has identified a previously unknown cellular mechanism crucial to the ...

The discovery could serve as a starting point for antiviral strategies. A research team at Ruhr University Bochum, Germany, ...

Current treatments for herpes simplex virus 1 (HSV-1) mainly target the viral DNA polymerase, but resistance is becoming an increasing problem. By understanding how HSV-1 initiates replication, ...